Micropuncture study of diuretic effects on sodium and calcium reabsorption in the dog nephron.
A close relationship has been observed between the clearance rates of sodium and calcium under a variety of diuretic conditions. The thiazide diuretics act differently in dissociating the renal tubular reabsorption of sodium and calcium. This phenomenon has been further investigated using recollection micropuncture and clearance techniques in a group of 14 dogs subjected to three consecutive experimental phases: expansion to 3% of body weight (BWt) with Ringer's solution, chlorothiazide infusion at 20 mg/kg/h, and furosemide in a prime of 10 mg/kg/ and a 10 mg/kg/h infusion. Diuretic losses were balanced with infusion of equal volumes of Ringer's solution throughout the experiment. Chlorothiazide increased the fractional excretion (FE) of sodium almost threefold while FE(Ca) was not significantly altered. Furosemide increased FE(Na) and FE(Ca) to an approximately equal, and more marked, degree. This dissociation of sodium and calcium reabsorption after chlorothiazide was also evident in the superficial distal tubule, where (tubule fluid/plasma sodium) (TF/P(Na)) increased from 0.32 to 0.49 (P < 0.01) and TF/(ultrafiltrate)UF(Ca) was unchanged (0.35-0.31). Furosemide markedly reduced the transtubular concentration gradient for both sodium (0.86) and calcium (0.94). TF/P(Inul in) decreased progressively from 3.79 to 2.78 to 2.33 in three phases. In the late proximal tubule, chlorothiazide induced a fall of TF/P(Inul in) from 1.57 to 1.44 (P < 0.01), but the ratio TF/UF(Ca): TF/P(Na) was unchanged. Furosemide had no significant proximal effect. It is concluded that acute administration of chlorothiazide reduces sodium reabsorption in the distal hephron, presumably the cortical diluting segment, without affecting calcium reabsorption.
D000818:Animals; D001158:Arteries; D001794:Blood Pressure / Q000187:drug effects; D001798:Blood Proteins / Q000032:analysis; D002118:Calcium / Q000378:metabolism* / Q000652:urine; D002740:Chlorothiazide / Q000494:pharmacology*; D004231:Diuresis / Q000187:drug effects; D004285:Dogs; D005665:Furosemide / Q000494:pharmacology*; D005919:Glomerular Filtration Rate; D006400:Hematocrit; D007668:Kidney / Q000187:drug effects*; D007684:Kidney Tubules / Q000378:metabolism; D007686:Kidney Tubules, Distal / Q000378:metabolism; D007687:Kidney Tubules, Proximal / Q000378:metabolism; D008657:Metabolic Clearance Rate; D009399:Nephrons / Q000187:drug effects; D011677:Punctures; D012964:Sodium / Q000378:metabolism* / Q000652:urine; D012965:Sodium Chloride / Q000494:pharmacology
D001798:Blood Proteins; D012965:Sodium Chloride; D002740:Chlorothiazide; D005665:Furosemide; D012964:Sodium; D002118:Calcium